Primary lung adenocarcinoma in transplanted lung in post bilateral lung transplantation.

Bi lateral lung transplant adenocarcinoma of the lungs cardiothoracic surgery lung transplant malignancy in transplanted lungs

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 23 02 2023
revised: 05 05 2023
accepted: 22 05 2023
medline: 3 7 2023
pubmed: 3 7 2023
entrez: 3 7 2023
Statut: epublish

Résumé

Primary lung cancer was reported by a bilateral lung transplant patient without any risk factors. Single lung transplantation should be contemplated instead of double lung transplantation as it has been shown to increase the risk of lung cancers. This is a case report of a 37-year-old woman, with no history of smoking, who developed adenocarcinoma in her transplanted lung 17 years post transplantation. The development of lung cancer 17 years after transplantation is considered as a rare finding in this case report. According to the Annual Report on Cardiothoracic Organ Transplantation 2019-2020, the NHS Blood and Transplant Data, approximately 156 lung transplants were performed in the UK during 2019-2020. The third most common primary disease group recipient was cystic fibrosis and bronchiectasis. There are several medical complications described in the recipients' post-lung transplantation, and the increased risk of lung malignancy due to immunosuppression is well-established in comparison to the general population. Most cancers, however, develop in the native lung following a single lung transplant. Several cases of lymphoproliferative malignancies in the transplanted lung have been reported following bilateral lung transplantation. This is a case report of a 37-year-old woman with no history of smoking who developed adenocarcinoma in her transplanted lung 17 years later. This patient underwent lobectomy via thoracotomy and was discharged home in good condition. Only a few cases of patients developing primary lung cancer in the transplanted lung with no recipient risk factor have been reported in the literature to date. The development of lung cancer 17 years after transplantation was a rare finding in this case report.

Identifiants

pubmed: 37397580
doi: 10.1002/ccr3.7489
pii: CCR37489
pmc: PMC10307987
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e7489

Informations de copyright

© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

Authors have no conflict of interest to disclose.

Références

Chest. 2001 Sep;120(3):1030-1
pubmed: 11555546
J Thorac Dis. 2016 Nov;8(Suppl 11):S915-S924
pubmed: 27942415
BMJ Open Respir Res. 2022 Apr;9(1):
pubmed: 35410891
Respir Med. 2015 Mar;109(3):427-33
pubmed: 25616348
Am J Transplant. 2019 May;19(5):1478-1490
pubmed: 30565414
Ann Transl Med. 2020 Mar;8(6):416
pubmed: 32355860

Auteurs

Fathima Shafra Mubarak (FS)

Cardiothoracic Surgery Harefield Hospital Harefield UK.

Sanjay Agrawal (S)

Harefield Hospital Harefield UK.
Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.

Jagan Rao (J)

Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK.

Classifications MeSH